Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Delaware for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Delaware only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Delaware (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Cozzolino (NPI 1144278722)

Field	Value
Entity Type	Individual
Organization	David Cozzolino
Address	2000 Foulk Road
City	Wilmington
State	DE
ZIP	19810
Taxonomy	Urology Physician
NPI Enumerated	May 5, 2006

Payer Source	Total Paid
Medicare	$786.9K
Medicaid	$0

Key Findings

Provider billing is concentrated in Medicare with total Medicare revenue of $786.9K and no Medicaid billing on file, making this effectively a single‑payer (Medicare) practice for the data on record. The absence of any Medicaid claims means payers should treat Medicaid exposure as negligible when assessing this provider’s footprint in Delaware.

Revenue concentration is high among a few drug and injection codes: J0775 ($231.8K, 30.3% of Medicare revenue), J3490 ($191K, 25.0%), and J0897 ($90.7K, 11.9%) — together these top three codes account for 67.2% of the provider’s Medicare revenue. This indicates the practice’s finances are materially driven by administration of injectable/infusible products and unclassified drug billing rather than a broad mix of low‑value office codes.

The code mix points to a urology practice structured around in‑office drug administration and procedural urology: high revenue from J0775 and J0897 (specialty injections) together with procedural codes such as 52000 (cystoscopy, $25.3K), 52648 (TURP, $8.1K), 50590 (ESWL, $13.1K) and 55875 (brachytherapy needle placement, $6.9K) suggests a mix of clinic‑based injections and operative/urologic procedural work. Additional items such as 11980 (hormone pellet insertion, $10.9K) and 54200 (penile injection, $4.5K) further support a breadth of office procedures and hormone/sexual‑health services.

Competitive standing on the top revenue drivers is mixed: J0775 ranks #10 of 97 providers nationally (91th percentile), indicating an above‑average national presence within a small peer group for that drug, while J3490 ranks #369 of 2838 (87th percentile) showing notable use of unclassified drug billing compared with peers. J0897 ranks #2795 of 10057 (72th percentile), which is solid but not exceptional, so the provider is a meaningful participant for these injectable therapies but not a dominant national leader across all specialty injectables.

The practice shows a pronounced outlier in office E/M volume: 99213 has 976 claims and $58.6K revenue and the provider ranks #6800 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). This unusually high E/M claim volume suggests heavy outpatient visit throughput or consistent low‑level visit coding relative to the national distribution and is an important operational signal for utilization review or panel‑size comparisons.

Ancillary and lab testing is a visible component of the billing mix: 87798 (989 claims, $33.6K, 4.4%) plus other amplified probe lab codes (87653, 87481, 87640) together represent recurring lab/service revenue, consistent with in‑office or closely affiliated lab testing and screening activities. Payers evaluating network value should note these recurring lab-style codes as part of the provider’s service footprint, not just procedural or drug revenue.

Tenure data show the provider’s NPI was enumerated 2006-05-05 (~20 years ago), indicating a long‑standing presence in the market; this longevity can correlate with an established referral base and stable patient panel which helps contextualize the sustained revenue from high‑volume drug administration codes. Long tenure combined with concentrated revenue streams suggests an established clinical focus rather than a newly shifted practice pattern.

From a contracting and risk perspective, reliance on high‑revenue drug administration and J3490 (an unclassified drug code with $191K revenue, 25.0% of Medicare revenue) creates concentration risk and a negotiation point: top codes J0775, J3490, and J0897 together represent 67.2% of Medicare revenue, so changes in drug pricing, coverage policies, or coding practices for those items would disproportionately impact the provider’s revenue. Given the lack of Medicaid billing, payers should also note this provider’s financial exposure is concentrated on Medicare reimbursement dynamics rather than a diversified payer mix.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

39 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0775	Injection, collagenase, clostridium histolyticum, 0.01 mg	5,040	$50	$231.8K
J3490	Unclassified drugs	180	$1,040	$191K
J0897	Injection, denosumab, 1 mg	5,040	$20	$90.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	980	$60	$58.6K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	250	$140	$33.8K
87798	The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified…	990	$30	$33.6K
52000	In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a…	150	$170	$25.3K
50590	Extracorporeal shock wave lithotripsy (ESWL) is a procedure used to destroy calculus (kidney stones) in the kidneys and ureters.	30	$450	$13.1K
11980	The provider inserts hormone pellets subdermally, normally under the patient's arm skin. These pellets then release levels of synthetic hormones (testosterone and/or estradiol) to treat menopausal…	160	$70	$10.9K
99203	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider…	130	$80	$10.2K

Showing 1–10 of 39

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 39 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Delaware Distribution

David Cozzolino — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Delaware

Full comparison — all codes billed, vs. state median

39 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0775	1	10	3,510	$50	$167.9K
J0897	20	60	3,360	$20	$132.9K
J3490	1	10	50	$990	$65.2K
87798	8	20	700	$30	$59.6K
J9217	6	30	160	$130	$31.1K
55875	6	10	10	$1,260	$29.1K
50590	6	20	30	$760	$26.5K
99214	1,367	1,830	150	$80	$25.5K
52000	11	30	100	$160	$21.4K
52648	4	10	20	$940	$19.8K

Showing 1–10 of 39

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Cozzolino, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Brandywine Urology Consultants PA	DE	Urology Physician	$0	$1.2M
Andrew Glick	DE	Urology Physician	$587.2K	$0
Helen Reidler	MD	Medical Physician Assistant	$578.4K	$0
Thomas Desperito	DE	Urology Physician	$413.3K	$0
Michael Lobis	DE	Urology Physician	$388.3K	$0
Bruce Benge	DE	Urology Physician	$365.5K	$0
Christopher Mitchell	DE	Urology Physician	$357.6K	$0
Steven Terranova	DE	Urology Physician	$352.1K	$0
Mona Yezdani	DE	Urology Physician	$337.3K	$0
Justin Sausville	DE	Urology Physician	$162.3K	$0

Nearby Providers

Other providers in the same ZIP code as David Cozzolino, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rachel A Maher,dmd, PA	DE	Dentist	$0	$4.5M
Brandywine Pediatric Dentistry, P.A.	DE	Pediatric Dentistry	$0	$4M
Jason Kaplan	DE	Ophthalmology Physician	$2.7M	$0
Brandywine Pediatrics, P.A.	DE	Pediatrics Physician	$0	$1.6M
Harry Lebowitz	DE	Ophthalmology Physician	$1.1M	$0
Rehabilitation Associates, P.A.	DE	Physical Medicine & Rehabilitation Physician	$0	$852.8K
Andrew Barrett	DE	Ophthalmology Physician	$671.1K	$0
Chloe Payne	DE	Dermatology Physician	$541.5K	$11.7K
James Fierro	DE	Family Medicine Physician	$530.7K	$0
Clifford L. Anzilotti, D.m.d., P.A.	DE	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$510.8K

David Cozzolino — Billing Profile & Reimbursement Data

Sign up for David Cozzolino — Billing Profile & Reimbursement Data policy alerts

David Cozzolino — Billing Profile & Reimbursement Data

Sign up for David Cozzolino — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References